Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Teva Pharmaceutical Industries Insider Sold Shares Worth $14,356,802, According to a Recent SEC Filing

Teva Pharmaceutical Industries Insider Sold Shares Worth $14,356,802, According to a Recent SEC Filing

MT newswireMT newswire2026/09/22 20:28
04:28 PM EDT, 09/22/2026 (MT Newswires) -- Roberto Mignone, Director, on September 19, 2026, sold 367,600 shares in Teva Pharmaceutical Industries (TEVA) for $14,356,802. Following the Form 4 filing with the SEC, Mignone has control over a total of 119,807 ordinary shares of the company, with 119,807 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/818686/000119312526397959/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion

Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.

智通财经•2026/11/10 04:31

Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output

Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.

智通财经•2026/11/10 04:12